Sanofi Says Kevzara Drug Fails as Possible COVID-19 Treatment Sanofi Says Kevzara Drug Fails as Possible COVID-19 Treatment
The rheumatoid arthritis drug Kevzara has failed as a COVID-19 treatment, French drugmaker Sanofi said on Tuesday following a similar flop of a Roche product.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Arthritis | COVID-19 | France Health | Health | Infectious Diseases | Rheumatoid Arthritis | Rheumatology